Trijardy XR is a combination oral medication made up of empaglifilozin, metformin, and linagliptin that lowers blood glucose levels.
Trijardy XR lowers blood glucose by helping the pancreas produce more insulin and slowing carbohydrate absorption. Metformin decreases the glucose production excreted from the liver. Empaglifilozin decreases the glucose level in the blood by filtering the excess glucose through the urine and is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes and heart disease.
When taking Trijardy XR, daily water intake should be increased. This medication, which comes in various doses, can be taken with other oral medications such as sulfonylureas and long-acting insulin, but it may require dose adjustment to reduce the risk of hypoglycemia (sometimes called low blood sugar).
- Trijardy XR is used in adults with type 2 diabetes to improve blood glucose management. It is also used to lower the risk of death from heart attack, stroke, or heart failure in adults with diabetes and heart disease. It is not for treating type 1 diabetes.
- Trijardy XR is usually taken in the morning with a meal.
- The initial dose of Trijardy XR is individualized based on the current treatment regimen. Your doctor will monitor its effectiveness and tolerability to adjust the dose as appropriate.
- Common side effects may include GI intolerance, headache, cold-like symptoms, increased urinary frequency, dizziness, and genital-urinary infections.
Trijardy XR Specs
Key specification
General Information
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
